Videos
Getting Started - SeqSolve™ 1
Loading Videos...

* * * * * *

About Us

Integromics S.L. provides state-of-the-art bioinformatics software solutions for data management and data analysis in genomics and proteomics. Our advanced software technology, supported by an experienced and knowledgeable team of life science professionals, enhances your ability to effectively organize your data, perform validated analyses, discover new biomedical knowledge and gain well-founded insights into various areas of research. We operate in the global life sciences market, with headquarters in Granada, subsidiaries in the US and distributors in 10 countries. We have established a network of collaborations with major international technology providers, including PerkinElmer, Life Technologies, TIBCO Spotfire, top pharmaceutical companies and renowned academic institutions.

  Click on the year to know the main milestones of our history:

  • 2003-05
  • 2003-05
  • 2006-08
  • 2009-11
  • 2012
  • 2013
  • 2014
  • 2005

    Integromics Launches its First Product, ArrayHub. ArrayHub  is a LIMS software solution that offers clients the latest technology to effectively store, organize and analyse data in microarray experiments. This application allows life science researchers to organize all the descriptive information for each task performed during microarray experiments, such as: experimental factors, hybridization, samples, images and files. First sale of ArrayHub.

    Integromics Establishes General Development Agreement with Spotfire. This agreement gave Integromics the right to use the Spotfire software in product development.

    Integromics Receives Neotec Fund for Business Consolidation. The Neotec Initiative seeks to support the creation and consolidation of new technology-based companies in Spain. Integromics was selected because of the excellence of its R&D projects.

    2003

    Opening of Offices in Madrid and Granada. Integromics opened two offices in Spain located in the Scientific Park of Madrid and in the Health Sciences Technologic Park of Granada. In both offices, specialized personnel is dedicated to the continuous innovation of Integromics products.

    Best Spin-off Prize from the University of Málaga. From the very beginning, Integromics has been acknowledged for the outstanding quality of its business projects.

    Integromics Starts Activity. Integromics was founded as a spin-off of the National Center for Biotechnology (CNB / CSIC) in Spain and the University of Malaga. Principal founder Dr. Jose Maria Carazo was motivated by a clear market need to develop new computational methods for analyzing data, with the Company’s first product addressing the needs of the microarray data analysis market (ArrayHub).

  • 2005

    Integromics Launches its First Product, ArrayHub. ArrayHub  is a LIMS software solution that offers clients the latest technology to effectively store, organize and analyse data in microarray experiments. This application allows life science researchers to organize all the descriptive information for each task performed during microarray experiments, such as: experimental factors, hybridization, samples, images and files. First sale of ArrayHub.

    Integromics Establishes General Development Agreement with Spotfire. This agreement gave Integromics the right to use the Spotfire software in product development.

    Integromics Receives Neotec Fund for Business Consolidation. The Neotec Initiative seeks to support the creation and consolidation of new technology-based companies in Spain. Integromics was selected because of the excellence of its R&D projects.

    2003

    Opening of Offices in Madrid and Granada. Integromics opened two offices in Spain located in the Scientific Park of Madrid and in the Health Sciences Technologic Park of Granada. In both offices, specialized personnel is dedicated to the continuous innovation of Integromics products.

    Best Spin-off Prize from the University of Málaga. From the very beginning, Integromics has been acknowledged for the outstanding quality of its business projects.

    Integromics Starts Activity. Integromics was founded as a spin-off of the National Center for Biotechnology (CNB / CSIC) in Spain and the University of Malaga. Principal founder Dr. Jose Maria Carazo was motivated by a clear market need to develop new computational methods for analyzing data, with the Company’s first product addressing the needs of the microarray data analysis market (ArrayHub).

  • 2008

    Integromics Signs a Preferential Agreement with Omics-Engineering. Integromics partners with Omics-Engineering, Hong-Kong (China), a software engineering company.

    Integromics Partners with TIBCO Spotfire to Develop IBD. Integromics enters into a co-development deal with TIBCO Spotfire to build Integromics Biomarker Discovery, a new product for functional genomics based on the new TIBCO Spotfire analytics and visualization platform. A year later, the two companies enter into a distribution agreement to sell each other’s products in the Life Sciences market.

    2007

    Opening of an Office in Philadelphia (USA). Seeking to build on its success in the European market, the Company opens its US headquarters by founding a US sales and marketing subsidiary in Philadelphia. The company expands to the US to address growing global demand for its products and to forge closer ties with North American customers, business partners and prospects.

    Integromics Partners with Several European Projects. Integromics establishes key scientific collaborations with European research institutions and companies in the context of EU FP7 collaborative projects (LipidomicNet, Resolve, Proactive).

    Integromics Signs a Preferential Agreement with Varbanov Soft – a Bulgarian software engineering company.

    Integromics Launches the First version of RealTime StatMiner. RealTime StatMiner is a high-performance software specifically designed for the new era of quantitative Applied Biosystems real-time PCR instrumentation and TaqMan Assays. RealTime StatMiner is also conceived as a plugin for Spotfire DecisionSite, powered by powerful statistics from Bioconductor. The software aims at providing accurate relative quantification by a powerful combination of interactive visualization, advanced statistics and data mining. The functional features provided in the software make it possible to simultaneously analyze hundreds of samples in different applications, like biomarker discovery, miRNA profiling and Copy Number Variation. First sale of RealTime StatMiner.

    Integromics Signs a Co-marketing Agreement with Applied Biosystems. The co-marketing agreement grants Applied Biosystems the right to commercialize RealTime StatMiner and establishes sales and marketing agreements.

    Integromics Provides the Scientific Software Platform for Andalusian Univeristies. Integromics wins the public tender and is selected to develop a Genomics platform for the Region of Andalusia in Spain. The project is funded by the governments of Spain and the Andalusia region, in an effort to build support for Life Science practices throughout Southern Spain. The University of Málaga and the University of Córdoba are responsible for the coordination of the platform.

    2006.

    Integromics Launches AB1700 Guide and Limma Guide. First sale of these products.

    Integromics Joins the Affymetrix GeneChip-compatible Applications Program. Integromics a leading provider of software solutions for data management and data analysis in Genomics and Proteomics around the world, announces that it has joined the Affymetrix GeneChip-compatible Applications Program and that ArrayHub has achieved GeneChip-compatible status with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip microarray platform.

  • 2011

    Integromics and Ingenuity Expand Their Cooperation with the Integration of a Fourth Integromics Product into Ingenuity’s IPA. Integromics extends its partnership with Ingenuity, a provider of information and analytics solutions for Life Science researchers. The partnership extension involves the scheduled integration of Integromics’ fourth product, SeqSolve, to offer the most complete collection of Omics tools available.

    Integromics Launches OmicsHub Proteomics 2.0, a latest version of the OmicsHub analysis product for mass spectrometry. This launch represents for the company a step forward to offer a new web-based multi-user, centralized data management and analysis tool for proteomics laboratories and healthcare facilities.

    Integromics Presents at the TIBCO Spotfire European User Conference. Integromics is an important partner of Spotfire in developing and bringing to market scientific applications for bioinformatics, genomics and proteomics research.  Integromics presents on ‘Next Generation Sequencing Data Analysis in Spotfire’ and on ‘Integrating Computational Data Analysis Capabilities into Analytic Applications’.

    Integromics Partners with FPGMX to Develop Low-Cost Methods for Clinical Genomics. Integromics enters into a partnership with Professor Angel Carracedo, recipient of the European Life Technologies ‘Ion Torrent Visionary Winners Award’, and his team at the Galician Foundation of Genomic Medicine (FPGMX) to implement the ApliClinics project, for the development of inexpensive solutions for Clinical Genomics.

    2010

    Integromics Contributes to the Establishment of New Proteomics Standards. Integromics collaborates with top European Proteomics institutions in the ProteomeXchange Consortium that has been set-up to provide a single point of submission for MS Proteomics data to key proteomics repositories and to encourage data exchange between them for optimal data dissemination.

    Integromics Launches SeqSolve for Next Generation Sequencing. The SeqSolve analysis software, exclusively designed for Next Generation Sequencing, performs tertiary level analyses for biologically-relevant results. It is designed with a high-performance computational core and a simple yet powerful user interface. The initial analysis with SeqSolve is published in Nature (Kapranov P. et al. Nature, July 29, 2010) and can be automatically performed in minutes on a laptop by the commercial version of SeqSolve.

    Integromics Partners with Cenix Biosciences to Develop Solutions for HCS. Integromics and Cenix Biosciences announce the collaboration to develop a novel platform for processing, organizing and analysing complex datasets from high throughput (HT), high content (HC) screening. The project builds on the cutting edge software solutions from Integromics and the expertise of the CRO Cenix in the field of HT-RNAi screening together with the powerful data processing workflow engine KNIME and the industry standard platform for interactive data visualization Spotfire. This deal helped Integromics to developed bioinformatics applications for HCS.

    Sale of the first Site License for RealTime StatMiner to the National Cancer Institute of the US and ESTools Consortium. RealTime StatMiner is available to every researcher at the NCI, as well as to ESTools Consortium members. Researchers can use this gene expression software technology to effectively perform accelerated and validated bioinformatics analysis to gain new insights in the ever-advancing cancer research and discovery fields. The solution allows researchers from more than 300 labs to perform a standardized analysis of functional gene expression data, thereby offering a unified platform to look at gene expression.

    2009

    Creation of Integromics UK. Integromics opens a new office in the UK to consolidate customer relationships in EMEA territory.

    Integration of Integromics and Ingenuity’s Products for Comprehensive Genomic Analysis. Integromics and Ingenuity Systems announce the integration of RealTime StatMiner and Integromics Biomarker Discovery (IBD) for Tibco Spotfire with Ingenuity Pathway Analysis (IPA). The resulting platform provides a uniform solution for researchers to visualize and statistically assess genomics data and identify relevant biological processes and pathways. Researchers can now leverage a the streamlined workflow to integrate data from RealTime StatMiner and IBD for Tibco Spotfire directly into IPA for enhanced modeling, analysis and understanding of their biological data.

    Integromics Signs a Preferential Agreement with OmicsCo in Cali, Colombia, a software engineering company.

    Integromics Receives a Venture Investment from I + D Unifondo. Integromics raises their first round of venture investment due to the strong position in the market and high growth potential.Integromcis state of the art technology and highly qualified workforce were key drivers behind the investment decision.

  • Real Use Case for SeqSolve: RNA-seq Analysis of ENCODE Data to Explore the Human Transcriptome. Dr. Sylvain Foissac, former postdoc at an ENCODE associated lab, run bioinformatics analyses of RNA-seq data from the ENCODE project with SeqSolve solution from Integromics. He shows to the scientific community how SeqSolve can extend the repertoire of human genes and shed new light on the molecular processes that are involved with regulation of gene expression. The ENCODE project aims to identify and characterize all the functional elements of the human genome.

    Integromics Collaborates in the European Seminar Series from PerkinElmer Informatics focused in addressing The challenges of biological data management and analysis in life sciences. PerkinElmer Informatics aims to provide an end-to-end solution for researchers to spend more time on science by minimizing the time they spend collecting, collating, analyzing and managing data. Is in this context where Integromics collaborates presenting the use of OmicsOffice on TIBCO Spotfire platform to help drive scientific discovery in genomics.

    Tibco Spotfire Certifies Integromics as its Sole Partner in the Fields of Genomics, Proteomics and Bioinformatics. Integromics is recognized as an important partner for Tibco Spotfire for the development and marketing of scientific applications for genomics and proteomics research. Tibco Spotfire recommend Integromics solutions to their customers and prospects that require solutions for genomics and proteomics data analysis and highlights Integromics as an important channel for them to market into non-pharma customers in those segments.

    Integromics Launches OmicsOffice Platform, a total solution that provides a streamlined and common analysis environment to analyse results from different genomics technologies and the analytical tools to compare and achieve a higher level of results using these combinations. The product completes the existing  guided workflows for RNAseq, ChipSeq, qPCR and microarray based gene expression with a set of powerful modules for the downstream integration and analysis of results from these technologies. These new modules include extended and platform-independent functional analysis (featuring Gene Ontology and Gene Set Enrichment) as well as functionality for seamless integration of data from different gene expression analysis platforms.

    Integromics Launches RealTime StatMiner 4.3 on TIBCO Spotfire, a next version tool for qPCR analysis. The new release wide opens the RealTime StatMiner market to any researcher that uses qPCR, as it can upload and evaluate data from any qPCR vendor. Integromic’s RealTime StatMiner 4.3 product represents a major upgrade in terms of software functionality, with many new features, which were previously only available on the standalone version. TIBCO Spotfire users, including the top pharmas, can now benefit from the best qPCR analytics in their environment representing the powerful synergy between Integromics and TIBCO Spotfire. This version of RealTime StatMiner for qPCR data analysis on TIBCO Spotfire is a key milestone preceding the release of the OmicsOffice integrative environment on the same Spotfire platform.

    Integromics Launches SeqSolve 2.1,  for Next Generation Sequencing (NGS) Data Analysis. This new version of SeqSolve includes a scalable server mode, which allows for the remote processing of multiple analyses by several users. Integromics developes this latest version to meet the demands of pharmas, agribusinesses and core facilities. This launch allows the company to improve the user experience by allowing them to use their desktop while the analysis is processed and to retrieve the results on workstations and mobile devices, such as iPad.

  • Integromics Partners with PerkinElmer for the Exclusive Worldwide Distributorship of New OmicsOffice Genomics Software From Integromics. OmicsOffice v.5.0  enables rapid, relevant and reliable genomic analysis by providing a rich and flexible set of statistical and functional analysis tools specifically for the study and cross-validation of microarray, next generation sequencing and qPCR data on a single platform. OmicsOffice allows users of TIBCO Spotfire to handle, process, analyze and properly visualize diverse genomics data, even if they come from custom or third party data anlysis solutions. This partnership represents an excellent opportunity to bring the power of OmicsOffice to genomic researchers, as well as to accelerate the release of new Omics analysis tools.

    Integromics partners with the Celgene Institute for Translational Research Europe (CITRE) and the Centre of Studies and Technical Research (CEIT) to implement the SANSCRIPT project that aims to build new data analysis methods for clinical genomics studies. As genome sequencing continues to take footholds in diagnosis, prognosis and treatment of diseases, it is expected that the findings of the SANSCRIPT project, in terms of software and new methodologies, will enhance the reliability and significance of the next generation sequencing (NGS) technology in the pipelines of drug development and clinical genomics studies. This deal helps Integromics to develop algorithms and statistical tools aimed at the identification of disease associated alterations, and strengthens its strategic focus in building software solutions for personalized medicine.

    Integromics Establishes a Key Collaboration with European HPC Experts to Develop New Big-data Computing Solutions for Genomics. Integromics enters in the Mr.SymBioMath consortium that is focused in the development of new methods to process quickly and efficiently the large data sets that are produced in genomics studies, typically based on Next Generation Sequencing technology, and their subsequent application in the early detection of drug reactions and allergies. The project will result in new software applications and data analysis methods to accelerate genomics adoption in the clinical domain. At the level of computation, the research will be focused on two major challenges: transmission of large volumes of data and optimization of genetic comparison models and visualizations. This deal represents an ideal opportunity for Integromics to reinforce its commitment to the development of software solutions for personalized medicine for clinics.

  • Integromics steps into the era of single-cell transcriptomics with the new Version 5.0 of the RealTime StatMiner® software for qPCR gene expression workflows.

    The new release opens the RealTime StatMiner market to researchers both from industry and academia that work on single-cell analysis. Moreover Version 5.0 addresses the new high throughput challenges for qPCR data analysis by including an improved data loader to easily handle large data files from any instrument platforms and a new method for normalization of data across multiple plates. In this way Version 5.0 enhances the reliability of qPCR data analysis from experiments that may have been performed at different times and locations. With the new interactive Principal Component Analysis (PCA) tool, now it is possible to identify outliers and clusters of genes or samples with similar expression patterns within datasets that are becoming increasingly larger and more complex. This version of RealTime StatMiner for qPCR data analysis is a key milestone that responds to the need of enhanced processivity of large data files and advanced statistical analysis of complex experimental results in the life science market.

   
 

“Frost & Sullivan Product Innovation of the Year” Award

The Frost & Sullivan Product Innovation of the Year Award recognizes Integromics’ excellence in new products and technologies serving the European Bioinformatics market. Integromics, S.L., has been recognized by Frost & Sullivan for its outstanding achievements in the Bioinformatics market in Europe. This award recognizes its tremendous efforts in research, establishing partnerships in industry and academia, high product penetration, value additions and clear distinction from competitors. The Frost & Sullivan Product Innovation of the Year Award is presented each year to the company that has demonstrated excellence in new products and technologies within their industry. The recipient company demonstrates innovation by launching a broad line of emerging products and technologies.

“Emprendedor XXI” Innovation Award

The Emprendedor XXI Award is one of the most prestigious symbols of recognition that a company in the process of expansion can achieve. The panel of judges is selected from a committee of renowned business and academic experts. Promoted by the Caixa and the DGPYME (Spanish Government), it has been created in order to incentivize enterprising initiatives and the creation of innovative companies in Spain Integromics competed against another 230 projects, mostly from the service, technological, media, and telecommunications sectors. The national winner received an award valued at 35,000 Euros, together with advice from an internationally renowned mentor who will guide the winning company through the development and growth process.

Accésit of “Premio Sello Innovación 2010” Award

The Premio Sello Innovación 2010 Award recognizes the excellence in knowledge transference R&D organizations and enterprises. it is promoted by the Association of Science and Technology Parks of Spain (APTE) with the support of the Spanish Government in the frame of the R&D Management Network Project. The Association of Science and Technology Parks of Spain (APTE) is a key piece of the Spanish Science – Technology – Company system. APTE members are science and technology parks that are located in 17 different autonomous communities. The companies and institutions located in those parks are the best the reference of the Spanish system of innovation.

Accésit of “Best Trajectory of a Technology-Based Innovative Enterprise (EIBT) 2011” Award

Integromics receives the EIBT national award for the company’s renowned performance as an innovative technology-based company. The EIBT Awards to the best performance as an innovative technology-based company are awarded by the National Association of European Business and Innovation Spanish Centers (ANCES) in collaboration with the Ministry of Industry, Energy and Tourism, the National Innovation Enterprise (ENISA) and the Center for Industrial and Technological Development (CDTI).These awards aim at social and institutional recognition of companies with strong scientific, technological and entrepreneurial activity as well as with services and products in the market characterized by high degree of innovation, development and differentiation. EIBT brand, under the Ministry of Industry, Energy and Tourism, is a distinction granted by ANCES to companies that, having received the support of the Program EIBT in the maturation period of the strategic plan, are guaranteed for the soundness of their business project and have a network of contacts established.

“Best presentation” Award of the Tech Media Europe 2012 & ICT Finance MarketPlace

Tech Media Europe 2012, organized by IAPMEI and Europe Unlimited, is a meeting point for early and growth stage startups, corporate and venture capital investors and industry players to network and discuss market opportunities and trends in the tech and media scene. Integromics was selected to present its business at ICT Finance MarketPlace held within TME 2012, Lisbon on 26th March, by an Investor Jury composed of Venture Capital and Corporate investors, Business Angels and relevant key industry players. Integromics was identified as one of the most promising innovating ICT SMEs across Europe and won theBest Presentation Award being automatically qualified for the European Venture Summit and therefore given a chance to reach the final of the European Venture Contest.


  • Jose Maria Carazo, PhD

  • Jose Maria Carazo, PhD

  • Alberto Pascual Montano, PhD

  • Vicente Rodríguez Carro, PhD

  • Oswaldo Trelles, PhD

  • Degree in Physics from the University of Granada and a PhD in Biological Sciences from the Universidad Autonoma de Madrid. Director of the Biocomputing Unit of the National Centre for Biotechnology (CNB-CSIC), the CSIC node of the National Bioinformatics Institute and the Instruct Image Processing Center. Currently he is science adviser for Integromics.

  • Degree in Physics from the University of Granada and a PhD in Biological Sciences from the Universidad Autonoma de Madrid. Director of the Biocomputing Unit of the National Centre for Biotechnology (CNB-CSIC), the CSIC node of the National Bioinformatics Institute and the Instruct Image Processing Center. Currently he is science adviser for Integromics.

  • PhD in Computer Science with 15 years of experience in biomedical research with applications in Clinical Microbiology, Medical Imaging, Neuroscience, Structural Biology, Image Processing and Bioinformatics. He currently heads the Bioinformatics Initiative of the CNB-CSIC. It has also been a consultant for companies such as Datamining (PolyVista, Inc.). Currently he is scientific advisor for Integromics.

  • BA and PhD in Philosophy from the UAM and the University of Münster (Germany), respectively. He`s a businessman with broad management experience at the head of different trading companies and multinational subsidiaries or agencies related to ICT. Currently he is strategic advisor for Integromics.

  • Degree in Industrial Engineering by Catholic University of Peru, MSc in Computer Sciences by the Polytechnic University of Madrid, Spain, MSc in Cellular & Molecular Biology at the University of Malaga and PhD. in Industrial Engineering by the University of Malaga. Director of the Bioinformatics & Information Technology Laboratory of the University of Malaga and of the Integrative Bioinformatics node of the Spanish National Bioinformatics Institute.

Víctor Canivell, PhD:Chief Executive Officer (CEO)
PhD in Physics from University of Barcelona and MBA from ESADE. He has a successfull 30 year track record in the ICT industry as EMEA VicePresident at Silicon Graphics, 3Com and Hewlett-Packard, as well as CEO of software startups Safelayer and Wisekey ELA. He is currently Chairman of the Board at ERA Biotech. He has worked and lived fourteen years in Switzerland, UK, Germany and the US.
Eduardo González-Couto, PhD: Chief Strategy Officer (CSO)
PhD in Molecular Genetics, University of Geneva, Switzerland, Dr. Gonzalez-Couto has extensive international experience in bioinformatics and sound scientific knowledge in drug development. He has spent his professional career in companies such as Glaxo Wellcome Experimental Research Inc, Geneprot and SienaBiotech Spa, where he was the leader of the drug discovery efforts in neurodegenerative diseases. He joined Integromics in 2009.
Juan Elvira: Chief Technical Officer (CTO)
Electronic Engineer with a masters degree in Multimedia Technologies by the Universidad de Granada. Previusly, he worked as a software engineer, chief of proyects and tecnical coordinator of Ericsson R&D and other companies. He joined Integromics in 2005.
Hilmar Berger, MD & PhD: R&D Director
MD and PhD in Medicine, University of Leipzig, Germany, Dr. Berger has further developed his career in the field of bioinformatics applied to clinical research. He has a long track of scientific publications in high impact journals of biomedicine and has participated in numerous international research projects. He joined Integromics in 2009.
     

Copyright © 2014 Integromics. All rights reserved.

Integromics®
Parque Tecnológico de Ciencias de la Salud, Avenida de la Innovación, nº 1, 18100 Armilla, Granada, Spain (+34) 958-560-057
215 South Century Avenue, #303, Waunakee, WI 53597, United States (+1) 608-850-4254
info@integromics.com
www.integromics.com